Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12621001366842Phase 2Recruiting
Phase 2, open-label, single-arm trial of estriol in vaginal stenosis, sponsored by Western Sydney Local Health District. Primary endpoints: Feasibility, compliance and acceptability, Incidence of vaginal stenosis and 1 more. Started May 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12621001366842.